Global Ganja Report

A US citizen is in court in the Persian Guld emirate of Dubai for possession of gummy-bear sweets laced with hashish, the United Arab Emirate's The National newspaper reported Dec. 20. Prosecutors told the Dubai Criminal Court that the defendant, identified only as "JD," had brought the cannabis candy in from the US. Working as a manager in the Emirates, JD was busted in July at a cafe by narcotics officers acting on a tip. He was apparently intimidated into accompanying the officers to his residence, where he spilled the beans±or the bears. "He opened his fridge and picked up a plastic bag full of gummy bears," testified a police major. Nonetheless, in his court appearance this week, JD pleaded ignorance. "I used it but I didn't know what it was at the time because it was inside the sweets," JD told the judges.  

On Dec. 18, Congress approved a $1.1 trillion dollar spending bill—and in the process approved a provision promising to keep federal law enforcement out of medical marijuana operations in states that have passed acts legalizing them. The provision, known as the Rohrabacher-Farr amendment, was first approved in December of last year. The rider for a second year bars the use of Department of Justice funds "to prevent such States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana."

Philadelphia Inquirer columnist Chris Goldstein got hold of a leaked 45-page internal equity report from high-finance titan Merrill Lynch, wealth management division of Bank of America, looking at the future prospects for America's cannabis industry. Goldstein wrote it up for his occassional series Philly420 Dec. 8 under the title "Merrill Lynch is bullish on marijuana." Goldstein finds: "Carefully researched, it was an interesting peek at how heavy hitters on Wall Street are starting to view the expanding industry."

Egyptian activist attorney Nasser Amin is challenging a law that calls for writers to be imprisoned for words that violate the country's "morals." The challenge comes in the trial of novelist Ahmed Naji, who could face two years in prison and a fine of nearly $1,300 for his work The Use of Life—because of its explicit sex scene and numerous references to hashish use. Amin argues that the law violates the Egyptian constitution, which only permits such punishment for published materials that are defamatory or encourage violence or discrimination.

Will the Bluegrass State beat the Golden State as the next to follow in the happy footsteps of Colorado, Washington, Oregon and Alaska by legalizing cannabis for recreational as well as medical use? WHAS11 in Louisville reported Dec. 11 that state Sen. Perry B. Clark (D-Louisville) pre-filed an act to legalize and regulate cannabis in a manner similar to how the state handles alcohol. The bill would repeal Kentucky's prohibition on cannabis cultivation, possession and sale. Instated in its place would be a "regulatory framework designed to promote public safety and responsible cannabis consumption by persons over 21 years of age."

San Francisco's Examiner reports Dec. 14 that city authorities, in anticipation that California voters will legalize recreational cannabis use next year, are assembling a body to propose regulations for the industry. The newly created Cannabis State Legalization Task Force. The body will advise the San Francisco Board of Supervisors. Last week, the board's Rules Committee selected 11 people to serve on the body, with three more seats still to be filled. One of the appointees is Erich Pearson, founder of SPARC, one of San Francisco's biggest dispensaries. "We need to determine how many cannabis users we are going to have in San Francisco and how many stores that's going to take to distribute that cannabis once it's legal," he told the Examiner.

After years of research into the question, in July of last year Israeli authorities made post-traumatic stress disorder the only psychiatric condition for which the Health Ministry will approve the use of medical marijuana. The decision, backed by the Israel Psychiatric Association, was a cause for optimism among many Israeli veterans suffering from PTSD. But a sobering account in Israeli daily Haaretz Dec. 8 finds that actually getting the stuff has proved difficult for sufferers—starting with the problem of getting the necessary doctor's recommendation, and then bureaucratic obstacles once they do. "We are a very small group of three or four psychiatrists who believe that in some PTSD cases cannabis is helpful," said psychiatrist Dr. Ilya Reznik, an Israeli executive board member of the International Association for Cannabinoid Medicines. "The pressure on our clinics is impossible. This is partly because people who get a permit and don’t come in every three months for follow-up risk losing their permit."

There have been quite a few histories of cannabis culture and politics, but Bruce Barcott's Weed The People: The Future of Legal Marijuana in America is the first to examine the cannabis industry and its future prospects at a moment when it is taking flight. His opening overview of how we got to this point is engaging if not always strictly accurate (he loans too much credence to the '70s paraquat scare). He notes the litany of US government reports back to the 1920s exculpating cannabis of the calumnies against it—all ignored by the very government that commissioned them. He details the bureaucratic obstacles that have been raised to research on cannabis' medical benefits. And he relates the passing of the torch (or, more literally, the joint) from the jazz scene to the beatniks to the hippies to the mainstream.